ARG-007 Reduces Effects of TBI in Preclinical Study
Released 14 May 24
Latest announcements
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Argenica Therapeutics a question about this announcement.
ARG-007 Reduces Effects of TBI in Preclinical Study
Latest announcements
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Argenica Therapeutics a question about this announcement.